These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24936240)

  • 1. Discovery of tetrahydroisoquinoline-based CXCR4 antagonists.
    Truax VM; Zhao H; Katzman BM; Prosser AR; Alcaraz AA; Saindane MT; Howard RB; Culver D; Arrendale RF; Gruddanti PR; Evers TJ; Natchus MG; Snyder JP; Liotta DC; Wilson LJ
    ACS Med Chem Lett; 2013 Nov; 4(11):1025-30. PubMed ID: 24936240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel N-aryl piperazine CXCR4 antagonists.
    Zhao H; Prosser AR; Liotta DC; Wilson LJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4950-4955. PubMed ID: 25935642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties.
    Nguyen HH; Kim MB; Wilson RJ; Butch CJ; Kuo KM; Miller EJ; Tahirovic YA; Jecs E; Truax VM; Wang T; Sum CS; Cvijic ME; Schroeder GM; Wilson LJ; Liotta DC
    J Med Chem; 2018 Aug; 61(16):7168-7188. PubMed ID: 30052039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.
    Skerlj RT; Bridger GJ; Kaller A; McEachern EJ; Crawford JB; Zhou Y; Atsma B; Langille J; Nan S; Veale D; Wilson T; Harwig C; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Apr; 53(8):3376-88. PubMed ID: 20297846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles.
    Jecs E; Tahirovic YA; Wilson RJ; Miller EJ; Kim M; Truax V; Nguyen HH; Akins NS; Saindane M; Wang T; Sum CS; Cvijic ME; Schroeder GM; Burton SL; Derdeyn CA; Xu L; Jiang Y; Wilson LJ; Liotta DC
    J Med Chem; 2022 Mar; 65(5):4058-4084. PubMed ID: 35179893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald Couplings.
    Nguyen HH; Tahirovic YA; Truax VM; Wilson RJ; Jecs E; Miller EJ; Kim MB; Akins NS; Xu L; Jiang Y; Wang T; Sum CS; Cvijic ME; Schroeder GM; Wilson LJ; Liotta DC
    ACS Med Chem Lett; 2021 Oct; 12(10):1605-1612. PubMed ID: 34676043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties.
    Miller EJ; Jecs E; Truax VM; Katzman BM; Tahirovic YA; Wilson RJ; Kuo KM; Kim MB; Nguyen HH; Saindane MT; Zhao H; Wang T; Sum CS; Cvijic ME; Schroeder GM; Wilson LJ; Liotta DC
    J Med Chem; 2018 Feb; 61(3):946-979. PubMed ID: 29350534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of
    Tahirovic YA; Truax VM; Wilson RJ; Jecs E; Nguyen HH; Miller EJ; Kim MB; Kuo KM; Wang T; Sum CS; Cvijic ME; Schroeder GM; Wilson LJ; Liotta DC
    ACS Med Chem Lett; 2018 May; 9(5):446-451. PubMed ID: 29795757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors.
    Wu CH; Wang CJ; Chang CP; Cheng YC; Song JS; Jan JJ; Chou MC; Ke YY; Ma J; Wong YC; Hsieh TC; Tien YC; Gullen EA; Lo CF; Cheng CY; Liu YW; Sadani AA; Tsai CH; Hsieh HP; Tsou LK; Shia KS
    J Med Chem; 2015 Feb; 58(3):1452-65. PubMed ID: 25584630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.
    De Clercq E; Schols D
    Antivir Chem Chemother; 2001; 12 Suppl 1():19-31. PubMed ID: 11594685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors.
    Toma J; Whitcomb JM; Petropoulos CJ; Huang W
    AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural analysis of CXCR4 - Antagonist interactions using saturation-transfer double-difference NMR.
    Cox BD; Mehta AK; DiRaddo JO; Liotta DC; Wilson LJ; Snyder JP
    Biochem Biophys Res Commun; 2015 Oct; 466(1):28-32. PubMed ID: 26301631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CXCR4 in HIV cell-entry inhibition.
    Steen A; Schwartz TW; Rosenkilde MM
    Mini Rev Med Chem; 2009 Dec; 9(14):1605-21. PubMed ID: 20088780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-peptidic chemokine receptors antagonists as emerging anti-HIV agents.
    Scozzafava A; Mastrolorenzo A; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Apr; 17(2):69-76. PubMed ID: 12420752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of CXCR4 antagonists in the treatment of HIV.
    Fujii N; Nakashima H; Tamamura H
    Expert Opin Investig Drugs; 2003 Feb; 12(2):185-95. PubMed ID: 12556213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.
    Jenkinson S; Thomson M; McCoy D; Edelstein M; Danehower S; Lawrence W; Wheelan P; Spaltenstein A; Gudmundsson K
    Antimicrob Agents Chemother; 2010 Feb; 54(2):817-24. PubMed ID: 19949058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach.
    Mirza MU; Saadabadi A; Vanmeert M; Salo-Ahen OMH; Abdullah I; Claes S; De Jonghe S; Schols D; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2020 Dec; 155():105537. PubMed ID: 32890663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.